← Back to Search

Cognitive Function in Substance Use Disorders

Phase 4
Waitlist Available
Led By Walter Ling, M.D.
Research Sponsored by National Institute on Drug Abuse (NIDA)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will compare the cognitive abilities of methamphetamine abusers to those of cocaine abusers and people with no drug abuse history.

Who is the study for?
This trial is for individuals who meet the DSM-IV criteria for dependence on cocaine or methamphetamine. Participants must agree to the study's conditions and sign informed consent.Check my eligibility
What is being tested?
The study aims to compare cognitive performance among three groups: those dependent on methamphetamine, those dependent on cocaine, and a control group with no substance use disorders.See study design

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)Lead Sponsor
2,468 Previous Clinical Trials
2,619,268 Total Patients Enrolled
Walter Ling, M.D.Principal InvestigatorFriends Research Institute, Inc.
38 Previous Clinical Trials
4,038 Total Patients Enrolled

Media Library

Treatment Clinical Trial Eligibility Overview. Trial Name: NCT00000346 — Phase 4
Amphetamine Use Disorder Research Study Groups:
Amphetamine Use Disorder Clinical Trial 2023: Treatment Highlights & Side Effects. Trial Name: NCT00000346 — Phase 4
Treatment 2023 Treatment Timeline for Medical Study. Trial Name: NCT00000346 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has this medicinal procedure been sanctioned by the Food and Drug Administration?

"The safety of this treatment is highly regarded, as it has been approved following Phase 4 trials. We have therefore evaluated the risk to be a 3 on our scale of 1-3."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
Friends Research Institute
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

Want to see if my cognitive abilities are up to par.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Cognitive Correlates of Substance Abuse - 11
2024. "Cognitive Correlates of Substance Abuse - 11". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00000346.
All > Substance Abuse
~53 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top